respiratory Archives -

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary

Verona cues up filings for COPD drug after it aces phase 3 test

https://pharmaphorum.com/news/verona-cues-up-filings-for-copd-drug-after-it-aces-phase-3-test/

Respiri brings wheezo device and app to US market

Phil Taylor asthma, digital, digital health, respiratory, Respiri, wheezo 0 Comment

Australian digital health company Respiri has rolled out its wheezo device, app and healthcare monitoring portal at Michigan

Respiri brings wheezo device and app to US market

https://pharmaphorum.com/news/respiri-brings-wheezo-device-and-app-to-us-market/

Events/ Events/ Partner Content

2nd ARDS Drug Development Summit

Jessica Durston ARDS, COVID-19, lung, R&D, respiratory

Only Industry-Specific Event for ARDS Drug Developers

2nd ARDS Drug Development Summit

https://pharmaphorum.com/events/2nd-ards-drug-development-summit/

Digital/ News/ News

Pfizer makes bid for ResApp and its respiratory diagnosis apps

Phil Taylor COVID-19, diagnostic, digital, digital health, M&A, Pfizer, ResApp Health, respiratory, sleep apnoea 0 Comment

Pfizer’s Australian unit has tabled an offer to buy ResApp Health and its smartphone apps for the management

Pfizer makes bid for ResApp and its respiratory diagnosis apps

https://pharmaphorum.com/news/pfizer-makes-bid-for-resapp-and-its-respiratory-diagnosis-apps/

News

Overuse of asthma inhalers linked to severe attacks; study

Phil Taylor asthma, inhalers, patients, respiratory 0 Comment

Data from a massive real-world study of asthma patients has suggested that overuse of inhalers is widespread and

Overuse of asthma inhalers linked to severe attacks; study

https://pharmaphorum.com/news/overuse-of-asthma-inhalers-linked-to-severe-attacks-study/

News/ News/ Sales and Marketing

Sandoz bulks up ahead of possible sale with Coalesce buy

Phil Taylor generics, M&A, Novartis, respiratory, Sandoz 0 Comment

Novartis may be planning to sell off its generics business Sandoz, but that hasn’t stopped it investing in

Sandoz bulks up ahead of possible sale with Coalesce buy

https://pharmaphorum.com/news/sandoz-bulks-up-ahead-of-possible-sale-with-coalesce/

News/ News/ R&D

Synairgen slumps as inhaled COVID drug fails pivotal test

Phil Taylor antiviral, coronavirus, COVID-19, interferon, respiratory, Synairgen 0 Comment

UK biotech Synairgen saw the value of its shares crater after its inhaled interferon beta therapy SNG001 was

Synairgen slumps as inhaled COVID drug fails pivotal test

https://pharmaphorum.com/news/synairgen-slumps-as-inhaled-covid-drug-fails-pivotal-test/

News/ News/ Patients

New diagnostic finds hidden lung damage in long COVID

Phil Taylor coronavirus, COVID-19, Long COVID, patients, respiratory 0 Comment

People with long-lasting symptoms of breathlessness after COVID-19 infection may have damage to their lungs that does not

New diagnostic finds hidden lung damage in long COVID

https://pharmaphorum.com/news/new-diagnostic-finds-hidden-lung-damage-in-long-covid/

Digital/ News/ News

Respira Labs’ wearable device listens for lung diseases

Phil Taylor asthma, COPD, COVID-19, digital, digital health, patient monitoring, Respira Labs, respiratory, Sylvee 0 Comment

US company Respira Labs has developed a device worn on the chest that uses tiny speakers and microphones

Respira Labs’ wearable device listens for lung diseases

https://pharmaphorum.com/news/respiras-wearable-device-listens-for-lung-diseases/

Trending

respiratory

Login